finland
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Spacetalk is re-entering the European market in partnership with Telkom giant Elisa in Finland as part of an expansion strategy designed to generate immediate revenue in alignment with the company’s operational goals.

Spacetalk said Finland was selected as the launch point due its strong market appeal for Spacetalk’s products aligned with Elisa’s extensive distribution network.

“Our aim is to establish a scalable, replicable business  model that enhances both device margins and recurring revenue,” Spacetalk said in its announcement to the ASX.

The partnership will see Spacetalk’s Adventurer 2 and Loop products becomg available in 67 Elisa stores and online, with presales already underway and the company aiming for a launch in June 2024.

As part of the agreement, Elisa will have a 12-month exclusive in the Finnish telco retail market.

The initial stock intake will be1600 Spacetalk devices with annual unit sales estimated at 5000 per annum.

“This move is not only set to generate significant hardware revenue but also provides the foundations for establishment of a steady stream of monthly recurring subscription income as product sales eventuate,” Spacetalk said.

With initial stock shipments already enroute from Spacetalk’s Australian facility to Finnish distribution centres, Spacetalk said it views expansion into Finland as a potential blueprint for further expansion into other markets.

spa by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next